top of page

Drug Facts Panel for Sunscreens: Getting Bemotrizinol Labeling Right

  • Writer: Alok Naik, MS- Regulatory Affairs
    Alok Naik, MS- Regulatory Affairs
  • 4 days ago
  • 2 min read

Updated: 13 hours ago

When an international sunscreen fails to make it onto a U.S. shelf, the label is usually why. In the United States, sunscreens are OTC drugs, and that means a Drug Facts panel — a strict, standardized format that looks nothing like a cosmetic label. Here's what it requires and where bemotrizinol products go wrong.

What the Drug Facts panel must contain

The panel follows a fixed order and wording. At a minimum it covers:

  • Active ingredient(s) — including bemotrizinol and its concentration (up to 6%), with purpose.

  • Purpose — e.g., sunscreen.

  • Uses — the permitted use statements for sunscreens.

  • Warnings — including the required skin-cancer/skin-aging and other monograph warnings.

  • Directions — application and reapplication instructions.

  • Other information and inactive ingredients.

Claims you can and can't make

Your SPF value, broad-spectrum designation, and any water-resistance claim must each be supported by testing on the final formulation under the monograph's methods. Claims that outrun the data — or use language the monograph doesn't permit — are a fast route to a misbranding problem.

Where bemotrizinol labels go wrong

The recurring errors are predictable: a home-market layout never converted to Drug Facts; an active-ingredient declaration that doesn't match the formulation; SPF or broad-spectrum claims without matching test reports; and missing or reworded mandatory warnings. Each is fixable before launch — and far cheaper to fix before than after.

Get it reviewed before you print

A label review against the Drug Facts format and your supporting tests is one of the highest-leverage things you can do pre-launch. It's also the step brands most often skip.

Get the checklist

Labeling is one section of our Bemotrizinol (BEMT) U.S. Market-Entry Compliance Checklist. Download the free checklist → Or have Axentra review your label directly as part of the U.S. Market Entry Package.

Frequently asked questions

Can I keep my existing international sunscreen label for the U.S.?

Almost never as-is. U.S. sunscreens require a Drug Facts panel in a specific format, so most international labels need to be rebuilt.

Does my SPF claim need U.S. testing?

Your SPF, broad-spectrum, and water-resistance claims must be supported by testing on the final formulation under the monograph's methods.

What happens if my label isn't compliant?

A non-compliant label can render the product misbranded, which can lead to detention, refusal, or enforcement action.

Recent Posts

See All

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating

Stay in the know

Join our email list and get access to important updates curated only for  our subscribers.

bottom of page